España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
SCYNEXIS
SCYX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
SCYNEXIS (SCYX) Forecast
News
Earnings
SCYNEXIS (SCYX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for SCYNEXIS (NASDAQ:SCYX) Stock
SCYNEXIS Stock (NASDAQ: SCYX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 06, 2024
SCYNEXIS Q3 EPS $(0.06) Beats $(0.07) Estimat...
Benzinga Newsdesk
Thursday, October 03, 2024
SCYNEXIS To Present Preclinical Data On Secon...
Benzinga Newsdesk
Wednesday, May 08, 2024
SCYNEXIS Q1 2024 GAAP EPS $0.01 Beats $(0.20)...
Benzinga Newsdesk
Tuesday, April 30, 2024
SCYNEXIS Presented Preclinical Data On Second...
Benzinga Newsdesk
Monday, April 01, 2024
Cantor Fitzgerald Reiterates Overweight on SC...
Benzinga Newsdesk
Friday, March 29, 2024
SCYNEXIS Q4 EPS $(0.39) Misses $(0.20) Estima...
Benzinga Newsdesk
Monday, January 29, 2024
SCYNEXIS Presented Preclinical Data On Second...
Benzinga Newsdesk
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Monday, January 08, 2024
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Friday, January 05, 2024
SCYNEXIS To Present Preclinical Data On Secon...
Benzinga Newsdesk
Thursday, January 04, 2024
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, January 03, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, January 02, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
SCYNEXIS Entered Into Binding MoU For Amendme...
Benzinga Newsdesk
Monday, November 13, 2023
SCYNEXIS Q3 EPS $(0.04) Vs $(0.62) Last Year,...
Benzinga Newsdesk
Tuesday, October 24, 2023
SCYNEXIS Presents New Preclinical Data On Sec...
Benzinga Newsdesk
Monday, October 16, 2023
SCYNEXIS To Present Preclinical Data On Secon...
Benzinga Newsdesk
Thursday, September 28, 2023
SCYNEXIS Recalls BREXAFEMME Nationwide Over P...
Benzinga Newsdesk
Monday, September 25, 2023
Gold Moves Lower; TransCode Therapeutics Shares Surge
Lisa Levin
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Nasdaq Turns Higher; SCYNEXIS Shares Plunge
Lisa Levin
Why Are Antifungal Focused Scynexis Stock Plunging Today?
Vandana Singh
U.S. Stocks Open Lower; Chicago Fed Index Falls In August
Lisa Levin
SCYNEXIS shares are trading lower after the c...
Benzinga Newsdesk
SCYNEXIS Is Recalling BREXAFEMME And Temporar...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
SCYNEXIS Shares Halted, News Pending
Benzinga Newsdesk
Wednesday, August 16, 2023
Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, August 15, 2023
Cantor Fitzgerald Reiterates Overweight on SC...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Market-Moving News for August 15th
Benzinga Newsdesk
Monday, August 14, 2023
SCYNEXIS Q2 EPS $2.46 Beats $1.55 Estimate, S...
Benzinga Newsdesk
Thursday, July 20, 2023
SCYNEXIS And Hansoh Pharma Announce NMPA Acceptance Of The New Drug Application For Ibrexafungerp In China
Happy Mohamed
Wednesday, June 21, 2023
SCYNEXIS Announces $25M First Development Mil...
Benzinga Newsdesk
Friday, May 12, 2023
SCYNEXIS Reports Closing Of Exclusive License Agreement With GSK For BREXAFEMME; SCYNEXIS Is Receiving An Upfront Payment Of $90M With Future Performance-Based Milestone Payments Of Up To $503M And Tiered Royalties
Happy Mohamed
Thursday, May 11, 2023
SCYNEXIS: Q1 Earnings Insights
Benzinga Insights
SCYNEXIS Q1 EPS $(0.71) Misses $(0.28) Estima...
Benzinga Newsdesk
Thursday, April 13, 2023
Kingdon Capital Management, L.L.C. Discloses ...
Benzinga Newsdesk
Monday, April 03, 2023
Looking Into SCYNEXIS's Return On Capital Employed
Benzinga Insights
Guggenheim Maintains Buy on SCYNEXIS, Raises ...
Benzinga Newsdesk
Ladenburg Thalmann Reiterates Buy on SCYNEXIS...
Benzinga Newsdesk
Friday, March 31, 2023
SCYNEXIS Q4 EPS $(0.30) Beats $(0.44) Estimat...
Bill Haddad
Thursday, March 30, 2023
SCYNEXIS, Maxim Raises Price Target To $10, G...
Happy Mohamed
Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
Lisa Levin
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks
Vandana Singh
SCYNEXIS shares are trading higher after the ...
Michael Horton
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch